Leyden Labs

Protecting Now From What Comes Next

Leiden, Netherlands · Founded 2021 · $320.0M raised

Headquarters
Leiden
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$320.0M
Last Round
$40.0M Venture RoundJun 2026
Rounds
7

About

Leyden Labs is a clinical-stage biotechnology company developing nasal sprays containing broadly-neutralizing antibodies that target respiratory viruses in the nasal mucosa. Their lead program PanFlu targets influenza A and B strains with a universal mechanism designed to protect against existing and future viral variants. Founded in 2020 and based in Leiden, Netherlands.

Summary

Leyden Labs is a Biotech company based in Leiden, Netherlands, founded in 2021. It has raised $320.0M in total across 7 rounds, most recently a $40.0M Venture Round round in Jun 2026. Investors include GV, Casdin Capital and European Innovation Council Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundJun 2026
$40.0M

Sign up to see all 7 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Leyden Labs on Indexed.vc
<a href="https://indexed.vc/companies/leyden-labs"><img src="https://indexed.vc/api/badge/company/leyden-labs" alt="Leyden Labs on Indexed.vc" width="260" height="76" /></a>